Christopher Astle - SVP & Chief Financial Officer at Zymeworks Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
SVP & Chief Financial Officer
Issuer Symbol
ZYME on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Christopher Astle since 11 Mar 2025

Holdings reported by Christopher Astle for Zymeworks Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Unit 30,000 $336,468 $11.22 05 Jan 2024 Direct Common Stock
Common Stock 6,503 $72,935 $11.22 08 Jan 2024 Direct
Stock Option (Right to Buy) 50,000 05 Jan 2024 Direct Common Stock

Transactions reported by Christopher Astle for Zymeworks Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.